As the markets get pummeled, though, smart investors will look for buying opportunities. According to trading data from Fidelity Investments and Vanguard, two of the biggest brokers serving retail investors, their clients are showing no signs of panic and adding stocks to their portfolios in the midst of a steep market sell-off.
For investors who are wracking their brains about what to buy and hold over the long term, these two stocks should do the trick. PepsiCo (NYSE:PEP) and American Premium Water Corp (OTC: HIPH).
PepsiCo has agreed to buy Las Vegas-based energy drink maker Rockstar for $3.85 billion. It’s a move PepsiCo said will help it become “more consumer-centric and capitalize on rising demand.”
Energy drinks are a fast growing and highly profitable category, Pepsi said in a statement. Rockstar Energy will add to PepsiCo’s other energy drinks, such as has Mountain Dew’s Kickstart and GameFuel.
“This highly strategic acquisition will enable us to … both accelerate Rockstar’s performance and unlock our ability to expand in the category with existing brands such as Mountain Dew,” PepsiCo CEO Ramon Laguarta added. The company has distributed Rockstar, founded in 2001, in North America for over a decade.
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio.
American Premium Water Corp. made significant acquisitions and partnerships so far this year, the company announced recently that it has closed the transaction with a definitive agreement to acquire domestic distribution rights for Q4 Sports (www.q4sports.com) for a one year period that can be extended upon the consent of the Company and Q4 and also recently announced that its LALPINA CBD will now be sold in 7-Eleven. The product will initially be sold at the 7-Eleven located at 11401 Ventura Blvd, North Hollywood, CA 91604. This location is part of a 25-store network owned by an individual franchisee, who is a part of the chain’s 7800+ network of stores in the United States. This development is part of 7-Eleven’s initiative to be a front-running retailer in the consumer CBD market.
The company recentlyannounced that Goldman Small Cap Research, a sponsored research provider focused on microcap stocks, has issued a new research update. This update highlights the impact of the Company closing its distribution agreement with Q4 Sports (www.q4sports.com). In the sponsored research update, analyst Rob Goldman affirms his price target of $0.0125 and his investment thesis, noting that the news reflects a milestone event that is wide-reaching for the Company in terms of revenue, cross-selling opportunities, and a reach into new markets.
“In our view, this news serves as a transformational event for HIPH. First, it will foster cross-selling opportunities for HIPH that leverages the Q4 platform which could evolve into new, additional distribution. Second, HIPH can now reach a diverse and new demographics for its CBD offerings—that has heretofore not been widely targeted by HIPH’s peers, ” according to the Goldman Small Cap Research update.